SS Innovations International Inc. (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an independent endorsement as the company continues to expand its presence in the global surgical robotics market. The award was presented after SS Innovations was selected from a field of ten finalists that included established medical technology companies such as Intuitive, Johnson & Johnson MedTech, Medtronic, and others (https://nnw.fm/mXdgs).
The recognition coincides with continued operational growth for the SSi Mantra surgical robotic platform. As of June 22, 2026, surgeons had completed a cumulative 11,719 multi-specialty procedures using the system, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric operations. The platform has been used across more than 170 different types of surgical procedures, reflecting its versatility across multiple disciplines.
Training has also expanded, with approximately 2,100 physicians completing training on the SSi Mantra platform. Physician education is a key factor in hospital purchasing decisions and long-term utilization of robotic surgery systems. The company’s commercial footprint has broadened internationally, with regulatory approvals granted in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine, and the United Arab Emirates.
The SSi Mantra is described as a modular, multi-arm robotic surgery platform with three to five robotic arms, a 3D 4K visualization system, an ergonomic surgeon console, and digital imaging capabilities. The instrument portfolio includes more than 40 robotic instruments, including 5-millimeter instruments for pediatric and ENT procedures. The company has also developed the SSi MantrAsana, a portable tele-surgeon console that supports remote surgical capabilities, with more than 20 cardiac telesurgeries performed using the platform.
Chairman and CEO Dr. Sudhir Srivastava said the award reflects the company’s focus on expanding access to robotic surgery while developing technologies to improve affordability for hospitals and healthcare systems. The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties, and manufacturers seek to expand beyond traditional markets. For investors, the recognition provides an independent industry endorsement as SS Innovations continues to grow.
